ADIL
Adial Pharmaceuticals Inc
NASDAQ: ADIL · HEALTHCARE · BIOTECHNOLOGY
$1.55
-0.64% today
Updated 2026-04-29
Market cap
$2.21M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-11.93
Dividend yield
—
52W range
$2 – $30
Volume
0.1M
Adial Pharmaceuticals Inc (ADIL) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-465222.00 | $-274384.00 | $-494862.00 | $-2.50M | $-6.34M | $-7.63M | $-11.95M | $-11.19M | $-6.81M | $-6.92M | $-6.49M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $64605.00 | $64605.00 | $64605.00 | $64605.00 | $5.00 | $6.81M | $0.00 | $3.00 |
| Depreciation | $565.00 | $565.00 | $565.00 | $563.00 | $565.00 | $564.00 | $55106.00 | $60501.00 | $564.00 | $565.00 | — |
| Stock-based comp | $250823.00 | $153563.00 | $205396.00 | $5.37M | $1.60M | $2.01M | $4.24M | $3.37M | $1.75M | $796831.00 | $676200.00 |
| Free cash flow | $-465222.00 | $-274384.00 | $-494862.00 | $-2.56M | $-6.40M | $-7.70M | $-12.01M | $-11.19M | $-13.61M | $-6.92M | $-6.49M |
| Investing cash flow | $35117.00 | $35117.00 | $35117.00 | $-350000.00 | $-350000.00 | $-350000.00 | $-34016.00 | — | $1.50M | — | — |
| Financing cash flow | $200000.00 | $200000.00 | $390000.00 | $6.35M | $9.25M | $5.61M | $13.64M | $9.13M | $4.13M | $7.85M | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $3.85M | $2.91M | $-2.38M | — | — | — | — | — |